Overview
Ilunocitinib is a cutting-edge Janus Kinase (JAK) inhibitor tablet designed specifically for dogs, offering fast-acting relief from persistent itching (pruritus) caused by allergic dermatitis and atopic (environmental) allergies. As a Class I veterinary drug licensed by Elanco, it breaks the itch-scratch-inflammation cycle, helping restore your dog's comfort and skin health without the need for steroids.
Key Functionalities
- Targets JAK enzymes to quickly reduce itch signals and inflammation.
- Provides noticeable relief within hours, with full effects in 24 hours.
- Once-daily dosing for easy, consistent management of chronic or flare-up symptoms.
- Suitable for long-term use under veterinary supervision.
Usage and Dosage
Administer orally once daily, with or without food. Dosage is weight-based (typically 0.5-1 mg/kg, but consult your vet for precise calculations). For dogs 12 months or older; not recommended for puppies, pregnant/lactating, or breeding dogs. Always start with baseline blood work and monitor regularly.
Potential Side Effects Common: Mild gastrointestinal upset (vomiting, diarrheas). Less common: Increased infection risk due to immune modulation, skin lumps, or lethargy. Rare: Serious reactions like demodicosis or vaccine interference-avoid use 28 days before/after vaccinations. Discontinue and contact your vet if symptoms worsen.
Why It's Important
Allergic itching affects up to 25% of dogs, disrupting daily life and leading to painful skin damage. Ilunocitinib empowers pet parents with an effective, affordable alternative to traditional treatments, improving quality of life for your furry companion. Available by prescription only-pair with allergy testing for best results. Consult your veterinarian before use.